Literature DB >> 1008999

The role of prostaglandins in chemically induced inflammation.

J S Chahl, L A Chahl.   

Abstract

Dye leakage in rats, produced by intracutaneous injections of irritants into the abdominal skin, was quantitated using the Evans blue technique of Harada et al. (1971). In control rats and in rats pretreated with indomethacin (an inhibitor of prostaglandin synthesis) concentration-response lines were obtained for 5-hydroxytryptamine, histamine, bradykinin and prostaglandin E1, bradykinin in the presence of prostaglandin E1 (10-6 M), adenosine-5'-triphosphate, compound 48/80, capsaicin and silver nitrate. In rats pretreated with indomethacin the dye leakage responses to histamine, prostaglandin E1, adenosine-5'-triphosphate and silver nitrate were significantly reduced, but no significant changes were observed in the responses to the other irritants. It is suggested that part of the action of histamine, adenosine-5'-triphosphate and prostagland in E1 is produced indirectly by releaseor stimulation of the synthesis of prostaglandins or their precursors. These results might have important implications in the understanding of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008999      PMCID: PMC2041239     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  13 in total

Review 1.  Prostaglandins and cutaneous inflammation.

Authors:  M E Goldyne
Journal:  J Invest Dermatol       Date:  1975-06       Impact factor: 8.551

2.  Prostaglandins, aspirin-like drugs and the oedema of inflammation.

Authors:  S Moncada; S H Ferreira; J R Vane
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

3.  Prostaglandins, cyclic nucleotides and cell function.

Authors:  F A Kuehl
Journal:  Prostaglandins       Date:  1974-02-25

4.  Effects of known and suspected neurotransmitter substances and of some nucleotides on isolated mast cells.

Authors:  J A Kiernan
Journal:  Experientia       Date:  1972-06-15

5.  The involvement of mast cells in vasodilatation due to axon reflexes in injured skin.

Authors:  J A Kiernan
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1972-07

6.  Prostaglandins as potentiators of increased vascular permeability in inflammation.

Authors:  T J Williams; J Morley
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

7.  Aspirin selectively inhibits prostaglandin production in human platelets.

Authors:  J B Smith; A L Willis
Journal:  Nat New Biol       Date:  1971-06-23

8.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

9.  Indomethacin and aspirin abolish prostaglandin release from the spleen.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

10.  Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

View more
  5 in total

1.  Cutaneous blood flow measurements: a standardization of the microsphere assay for vasoactive agents.

Authors:  P Vadas; J B Hay
Journal:  Agents Actions       Date:  1978-10

2.  Dependence of histamine-evoked nociception on prostaglandin release.

Authors:  H Juan
Journal:  Agents Actions       Date:  1981-12

3.  The appearance and significance of phospholipase A2 in lymph draining tuberculin reactions.

Authors:  P Vadas; J B Hay
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

4.  Histamine-induced release of arachidonic acid and of prostaglandins in the peripheral vascular bed: mode of action.

Authors:  H Juan; W Sametz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

5.  Pharmacology of the neurogenic oedema response to electrical stimulation of the saphenous nerve in the rat.

Authors:  C R Morton; L A Chahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.